{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:15:33Z","timestamp":1792700133341,"version":"4.5.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T00:00:00Z","timestamp":1364256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1038\/nrgastro.2013.49","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T07:32:54Z","timestamp":1364283174000},"page":"423-433","source":"Crossref","is-referenced-by-count":306,"title":["New insights into pancreatic cancer-induced paraneoplastic diabetes"],"prefix":"10.1038","volume":"10","author":[{"given":"Raghuwansh P.","family":"Sah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajan Jiv Singh","family":"Nagpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debabrata","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh T.","family":"Chari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,26]]},"reference":[{"key":"BFnrgastro201349_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","volume":"55","author":"A Jemal","year":"2005","unstructured":"Jemal, A. et al. Cancer statistics, 2005. CA Cancer J. Clin. 55, 10\u201330 (2005).","journal-title":"CA Cancer J. Clin."},{"key":"BFnrgastro201349_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/00000658-199603000-00007","volume":"223","author":"KC Conlon","year":"1996","unstructured":"Conlon, K. C., Klimstra, D. S. & Brennan, M. F. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann. Surg. 223, 273\u2013279 (1996).","journal-title":"Ann. Surg."},{"key":"BFnrgastro201349_CR3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1053\/j.seminoncol.2007.05.005","volume":"34","author":"ST Chari","year":"2007","unstructured":"Chari, S. T. Detecting early pancreatic cancer: problems and prospects. Semin. Oncol. 34, 284\u2013294 (2007).","journal-title":"Semin. Oncol."},{"key":"BFnrgastro201349_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/MPA.0b013e318209e05d","volume":"40","author":"JT Magruder","year":"2011","unstructured":"Magruder, J. T., Elahi, D. & Andersen, D. K. Diabetes and pancreatic cancer: chicken or egg? Pancreas 40, 339\u2013351 (2011).","journal-title":"Pancreas"},{"key":"BFnrgastro201349_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/mc.20771","volume":"51","author":"D Li","year":"2012","unstructured":"Li, D. Diabetes and pancreatic cancer. Mol. Carcinog. 51, 64\u201374 (2012).","journal-title":"Mol. Carcinog."},{"key":"BFnrgastro201349_CR6","doi-asserted-by":"publisher","first-page":"F9","DOI":"10.1530\/ERC-12-0105","volume":"19","author":"Y Cui","year":"2012","unstructured":"Cui, Y. & Andersen, D. K. Diabetes and pancreatic cancer. Endocr. Relat. Cancer 19, F9\u2013F26 (2012).","journal-title":"Endocr. Relat. Cancer"},{"key":"BFnrgastro201349_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/09595287330180P102","volume":"18","author":"R Bright","year":"1833","unstructured":"Bright, R. Cases and observations connected with disease of the pancreas and duodenum. Med. Chir. Trans. 18, 1\u201356 (1833).","journal-title":"Med. Chir. Trans."},{"key":"BFnrgastro201349_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1056\/NEJM193408232110801","volume":"211","author":"A Marble","year":"1934","unstructured":"Marble, A. Diabetes and pancreatic cancer. N. Engl. J. Med. 211, 339\u2013349 (1934).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201349_CR9","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1001\/archinte.1939.00180220074007","volume":"63","author":"FW Grauer","year":"1939","unstructured":"Grauer, F. W. Pancreatic carcinoma: a review of thirty-four autopsies. Arch. Intern. Med. 63, 884\u2013889 (1939).","journal-title":"Arch. Intern. Med."},{"key":"BFnrgastro201349_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.2337\/diab.7.4.308","volume":"7","author":"RC Green Jr","year":"1958","unstructured":"Green, R. C. Jr, Baggenstoss, A. H. & Sprague, R. G. Diabetes mellitus in association with primary carcinoma of the pancreas. Diabetes 7, 308\u2013311 (1958).","journal-title":"Diabetes"},{"key":"BFnrgastro201349_CR11","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1001\/jama.1995.03520440059037","volume":"273","author":"J Everhart","year":"1995","unstructured":"Everhart, J. & Wright, D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 273, 1605\u20131609 (1995).","journal-title":"JAMA"},{"key":"BFnrgastro201349_CR12","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1038\/sj.bjc.6602619","volume":"92","author":"R Huxley","year":"2005","unstructured":"Huxley, R., Ansary-Moghaddam, A., Berrington de Gonzalez, A., Barzi, F. & Woodward, M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br. J. Cancer 92, 2076\u20132083 (2005).","journal-title":"Br. J. Cancer"},{"key":"BFnrgastro201349_CR13","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1016\/j.ejca.2011.03.003","volume":"47","author":"Q Ben","year":"2011","unstructured":"Ben, Q. et al. Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur. J. Cancer 47, 1928\u20131937 (2011).","journal-title":"Eur. J. Cancer"},{"key":"BFnrgastro201349_CR14","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1007\/s00125-011-2316-0","volume":"54","author":"VA Grote","year":"2011","unstructured":"Grote, V. A. et al. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia 54, 3037\u20133046 (2011).","journal-title":"Diabetologia"},{"key":"BFnrgastro201349_CR15","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1002\/cncr.10493","volume":"94","author":"Y Ogawa","year":"2002","unstructured":"Ogawa, Y. et al. A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus. Cancer 94, 2344\u20132349 (2002).","journal-title":"Cancer"},{"key":"BFnrgastro201349_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/nrurol.2012.239","volume":"10","author":"C De Nunzio","year":"2012","unstructured":"De Nunzio, C. & Tubaro, A. Prostate cancer: diabetes and prostate cancer\u2014an open debate. Nat. Rev. Urol. 10, 12\u201314 (2012).","journal-title":"Nat. Rev. Urol."},{"key":"BFnrgastro201349_CR17","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/ERC-12-0324","volume":"20","author":"S Djiogue","year":"2013","unstructured":"Djiogue, S. et al. Insulin resistance and cancer: the role of insulin and insulin-like growth factors. Endocr. Relat. Cancer 20, R1\u2013R17 (2013).","journal-title":"Endocr. Relat. Cancer"},{"key":"BFnrgastro201349_CR18","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/ajg.2011.301","volume":"106","author":"H Yuhara","year":"2011","unstructured":"Yuhara, H. et al. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am. J. Gastroenterol. 106, 1911\u20131921 (2011).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201349_CR19","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/ijc.26165","volume":"130","author":"C Wang","year":"2012","unstructured":"Wang, C. et al. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int. J. Cancer 130, 1639\u20131648 (2012).","journal-title":"Int. J. Cancer"},{"key":"BFnrgastro201349_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2012.11.038","volume":"330","author":"R Vongsuvanh","year":"2013","unstructured":"Vongsuvanh, R., George, J., Qiao, L. & Poorten, D. V. Visceral adiposity in gastrointestinal and hepatic carcinogenesis. Cancer Lett. 330, 1\u201310 (2013).","journal-title":"Cancer Lett."},{"key":"BFnrgastro201349_CR21","first-page":"871","volume":"19","author":"A McTiernan","year":"2005","unstructured":"McTiernan, A. Obesity and cancer: the risks, science, and potential management strategies. Oncology 19, 871\u2013881 (2005).","journal-title":"Oncology"},{"key":"BFnrgastro201349_CR22","doi-asserted-by":"publisher","first-page":"240634","DOI":"10.5402\/2012\/240634","volume":"2012","author":"E Mannucci","year":"2012","unstructured":"Mannucci, E. Insulin therapy and cancer in type 2 diabetes. ISRN Endocrinol. 2012, 240634 (2012).","journal-title":"ISRN Endocrinol."},{"key":"BFnrgastro201349_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00006676-200308000-00007","volume":"27","author":"L Bonelli","year":"2003","unstructured":"Bonelli, L. et al. Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case-control study in northern Italy. Pancreas 27, 143\u2013149 (2003).","journal-title":"Pancreas"},{"key":"BFnrgastro201349_CR24","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/00006676-200010000-00014","volume":"21","author":"XZ Ding","year":"2000","unstructured":"Ding, X. Z., Fehsenfeld, D. M., Murphy, L. O., Permert, J. & Adrian, T. E. Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression. Pancreas 21, 310\u2013320 (2000).","journal-title":"Pancreas"},{"key":"BFnrgastro201349_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.annepidem.2009.11.010","volume":"20","author":"P Maisonneuve","year":"2010","unstructured":"Maisonneuve, P. et al. Past medical history and pancreatic cancer risk: results from a multicenter case-control study. Ann. Epidemiol. 20, 92\u201398 (2010).","journal-title":"Ann. Epidemiol."},{"key":"BFnrgastro201349_CR26","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1053\/j.gastro.2009.04.013","volume":"137","author":"D Li","year":"2009","unstructured":"Li, D., Yeung, S. C., Hassan, M. M., Konopleva, M. & Abbruzzese, J. L. Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology 137, 482\u2013428 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201349_CR27","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","volume":"330","author":"JM Evans","year":"2005","unstructured":"Evans, J. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R. & Morris, A. D. Metformin and reduced risk of cancer in diabetic patients. BMJ 330, 1304\u20131305 (2005).","journal-title":"BMJ"},{"key":"BFnrgastro201349_CR28","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.gastro.2005.05.007","volume":"129","author":"ST Chari","year":"2005","unstructured":"Chari, S. T. et al. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 129, 504\u2013511 (2005).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201349_CR29","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.cgh.2006.06.024","volume":"4","author":"S Gupta","year":"2006","unstructured":"Gupta, S. et al. New-onset diabetes and pancreatic cancer. Clin. Gastroenterol. Hepatol. 4, 1366\u20131372 (2006).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201349_CR30","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1158\/1055-9965.EPI-06-0188","volume":"15","author":"F Wang","year":"2006","unstructured":"Wang, F., Gupta, S. & Holly, E. A. Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Cancer Epidemiol. Biomarkers Prev. 15, 1458\u20131463 (2006).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"BFnrgastro201349_CR31","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1053\/j.gastro.2008.01.039","volume":"134","author":"R Pannala","year":"2008","unstructured":"Pannala, R. et al. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 134, 981\u2013987 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201349_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4149\/neo_2011_01_58","volume":"58","author":"T Krechler","year":"2011","unstructured":"Krechler, T. et al. Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus. Neoplasma 58, 58\u201364 (2011).","journal-title":"Neoplasma"},{"key":"BFnrgastro201349_CR33","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/1097-0142(19910115)67:2<486::AID-CNCR2820670228>3.0.CO;2-1","volume":"67","author":"E Cersosimo","year":"1991","unstructured":"Cersosimo, E. et al. Insulin secretion and action in patients with pancreatic cancer. Cancer 67, 486\u2013493 (1991).","journal-title":"Cancer"},{"key":"BFnrgastro201349_CR34","first-page":"101","volume":"159","author":"J Permert","year":"1993","unstructured":"Permert, J. et al. Pancreatic cancer is associated with impaired glucose metabolism. Eur. J. Surg. 159, 101\u2013107 (1993).","journal-title":"Eur. J. Surg."},{"key":"BFnrgastro201349_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/00006676-200305000-00012","volume":"26","author":"M Saruc","year":"2003","unstructured":"Saruc, M. & Pour, P. M. Diabetes and its relationship to pancreatic carcinoma. Pancreas 26, 381\u2013387 (2003).","journal-title":"Pancreas"},{"key":"BFnrgastro201349_CR36","first-page":"35","volume":"43","author":"TD Kim","year":"2004","unstructured":"Kim, T. D. et al. Clinical characteristics of pancreatic cancer according to the presence of diabetes mellitus [Korean]. Korean J. Gastroenterol. 43, 35\u201340 (2004).","journal-title":"Korean J. Gastroenterol."},{"key":"BFnrgastro201349_CR37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1245\/s10434-012-2577-y","volume":"20","author":"JM Wu","year":"2013","unstructured":"Wu, J. M. et al. Resolution of diabetes after pancreaticoduodenectomy in patients with and without pancreatic ductal cell adenocarcinoma. Ann. Surg. Oncol. 20, 242\u2013249 (2013).","journal-title":"Ann. Surg. Oncol."},{"key":"BFnrgastro201349_CR38","doi-asserted-by":"publisher","first-page":"414893","DOI":"10.1155\/2012\/414893","volume":"2012","author":"J Trna","year":"2012","unstructured":"Trna, J., Dite, P., Adamcova, A., Crawford, B. J. & Hermanova, M. Diabetes mellitus in pancreatic cancer patients in the Czech Republic: sex differences. Exp. Diabetes Res. 2012, 414893 (2012).","journal-title":"Exp. Diabetes Res."},{"key":"BFnrgastro201349_CR39","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/ijc.2910430312","volume":"43","author":"J Cuzick","year":"1989","unstructured":"Cuzick, J. & Babiker, A. G. Pancreatic cancer, alcohol, diabetes mellitus and gall-bladder disease. Int. J. Cancer 43, 415\u2013421 (1989).","journal-title":"Int. J. Cancer"},{"key":"BFnrgastro201349_CR40","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/ijc.2910410603","volume":"41","author":"RA Hiatt","year":"1988","unstructured":"Hiatt, R. A., Klatsky, A. L. & Armstrong, M. A. Pancreatic cancer, blood glucose and beverage consumption. Int. J. Cancer 41, 794\u2013797 (1988).","journal-title":"Int. J. Cancer"},{"key":"BFnrgastro201349_CR41","first-page":"499","volume":"33","author":"ET Bell","year":"1957","unstructured":"Bell, E. T. Carcinoma of the pancreas. I. A clinical and pathologic study of 609 necropsied cases. II. The relation of carcinoma of the pancreas to diabetes mellitus. Am. J. Pathol. 33, 499\u2013523 (1957).","journal-title":"Am. J. Pathol."},{"key":"BFnrgastro201349_CR42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.pan.2012.02.003","volume":"12","author":"G Aggarwal","year":"2012","unstructured":"Aggarwal, G., Rabe, K. G., Petersen, G. M. & Chari, S. T. New-onset diabetes in pancreatic cancer: a study in the primary care setting. Pancreatology 12, 156\u2013161 (2012).","journal-title":"Pancreatology"},{"key":"BFnrgastro201349_CR43","first-page":"101","volume":"159","author":"J Permert","year":"1993","unstructured":"Permert, J. et al. Pancreatic cancer is associated with impaired glucose metabolism. Eur. J. Surg. 159, 101\u2013107 (1993).","journal-title":"Eur. J. Surg."},{"key":"BFnrgastro201349_CR44","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1053\/gast.2001.27210","volume":"121","author":"ST Chari","year":"2001","unstructured":"Chari, S. T., Klee, G. G., Miller, L. J., Raimondo, M. & DiMagno, E. P. Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer. Gastroenterology 121, 640\u2013645 (2001).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201349_CR45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1053\/j.gastro.2007.10.040","volume":"134","author":"ST Chari","year":"2008","unstructured":"Chari, S. T. et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 134, 95\u2013101 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201349_CR46","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/bjs.1800800841","volume":"80","author":"J Permert","year":"1993","unstructured":"Permert, J. et al. Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br. J. Surg. 80, 1047\u20131050 (1993).","journal-title":"Br. J. Surg."},{"key":"BFnrgastro201349_CR47","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/MPA.0b013e3182592c96","volume":"42","author":"G Aggarwal","year":"2013","unstructured":"Aggarwal, G., Kamada, P. & Chari, S. T. Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers. Pancreas 42, 198\u2013201 (2013).","journal-title":"Pancreas"},{"key":"BFnrgastro201349_CR48","doi-asserted-by":"publisher","unstructured":"Tsoli, M. & Robertson, G. Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem. Trends Endocrinol. Metab. http:\/\/dx.doi.org\/10.1016\/j.tem.2012.10.006 .","DOI":"10.1016\/j.tem.2012.10.006"},{"key":"BFnrgastro201349_CR49","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","volume":"10","author":"K Fearon","year":"2013","unstructured":"Fearon, K., Arends, J. & Baracos, V. Understanding the mechanisms and treatment options in cancer cachexia. Nat. Rev. Clin. Oncol. 10, 90\u201399 (2013).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"BFnrgastro201349_CR50","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/PL00012351","volume":"23","author":"KC Fearon","year":"1999","unstructured":"Fearon, K. C. et al. Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia. World J. Surg. 23, 584\u2013588 (1999).","journal-title":"World J. Surg."},{"key":"BFnrgastro201349_CR51","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2214\/ajr.182.4.1820897","volume":"182","author":"S Gangi","year":"2004","unstructured":"Gangi, S. et al. Time interval between abnormalities seen on CT and the clinical diagnosis of pancreatic cancer: retrospective review of CT scans obtained before diagnosis. AJR Am. J. Roentgenol. 182, 897\u2013903 (2004).","journal-title":"AJR Am. J. Roentgenol."},{"key":"BFnrgastro201349_CR52","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1111\/j.1572-0241.2007.01480.x","volume":"102","author":"M Pelaez-Luna","year":"2007","unstructured":"Pelaez-Luna, M., Takahashi, N., Fletcher, J. G. & Chari, S. T. Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis. Am. J. Gastroenterol. 102, 2157\u20132163 (2007).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201349_CR53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/00006676-199707000-00009","volume":"15","author":"J Permert","year":"1997","unstructured":"Permert, J. et al. Islet hormone secretion in pancreatic cancer patients with diabetes. Pancreas 15, 60\u201368 (1997).","journal-title":"Pancreas"},{"key":"BFnrgastro201349_CR54","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/00006676-199405000-00008","volume":"9","author":"D Basso","year":"1994","unstructured":"Basso, D. et al. \u03b2-cell function in pancreatic adenocarcinoma. Pancreas 9, 332\u2013335 (1994).","journal-title":"Pancreas"},{"key":"BFnrgastro201349_CR55","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/BF01072886","volume":"23","author":"SS Schwarts","year":"1978","unstructured":"Schwarts, S. S., Zeidler, A., Moossa, A. R., Kuku, S. F. & Rubenstein, A. H. A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinoma. Am. J. Dig. Dis. 23, 1107\u20131114 (1978).","journal-title":"Am. J. Dig. Dis."},{"key":"BFnrgastro201349_CR56","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1056\/NEJM199402033300503","volume":"330","author":"J Permert","year":"1994","unstructured":"Permert, J. et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N. Engl. J. Med. 330, 313\u2013318 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201349_CR57","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/00004836-198904000-00020","volume":"11","author":"JA Rosa","year":"1989","unstructured":"Rosa, J. A., Van Linda, B. M. & Abourizk, N. N. New-onset diabetes mellitus as a harbinger of pancreatic carcinoma. A case report and literature review. J. Clin. Gastroenterol. 11, 211\u2013215 (1989).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnrgastro201349_CR58","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/BF01656023","volume":"8","author":"MD Silverstein","year":"1984","unstructured":"Silverstein, M. D., Richter, J. M., Podolsky, D. K. & Warshaw, A. L. Suspected pancreatic cancer presenting as pain or weight loss: analysis of diagnostic strategies. World J. Surg. 8, 839\u2013845 (1984).","journal-title":"World J. Surg."},{"key":"BFnrgastro201349_CR59","first-page":"143","volume":"86","author":"CM Girelli","year":"1995","unstructured":"Girelli, C. M., Reguzzoni, G., Limido, E., Savastano, A. & Rocca, F. Pancreatic carcinoma: differences between patients with or without diabetes mellitus. Recenti Prog. Med. 86, 143\u2013146 (1995).","journal-title":"Recenti Prog. Med."},{"key":"BFnrgastro201349_CR60","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1038\/ajg.2009.253","volume":"104","author":"R Pannala","year":"2009","unstructured":"Pannala, R. et al. Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer. Am. J. Gastroenterol. 104, 2318\u20132325 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201349_CR61","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1097\/MPA.0b013e318220816a","volume":"40","author":"PA Hart","year":"2011","unstructured":"Hart, P. A. et al. Weight loss precedes cancer-specific symptoms in pancreatic cancer-associated diabetes mellitus. Pancreas 40, 768\u2013772 (2011).","journal-title":"Pancreas"},{"key":"BFnrgastro201349_CR62","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.clnu.2009.11.006","volume":"29","author":"RA Murphy","year":"2010","unstructured":"Murphy, R. A. et al. Loss of adipose tissue and plasma phospholipids: relationship to survival in advanced cancer patients. Clin. Nutr. 29, 482\u2013487 (2010).","journal-title":"Clin. Nutr."},{"key":"BFnrgastro201349_CR63","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s001250051215","volume":"42","author":"MP Hermans","year":"1999","unstructured":"Hermans, M. P., Levy, J. C., Morris, R. J. & Turner, R. C. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 42, 678\u2013687 (1999).","journal-title":"Diabetologia"},{"key":"BFnrgastro201349_CR64","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2337\/diabetes.48.9.1779","volume":"48","author":"MP Hermans","year":"1999","unstructured":"Hermans, M. P., Levy, J. C., Morris, R. J. & Turner, R. C. Comparison of tests of \u03b2-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 48, 1779\u20131786 (1999).","journal-title":"Diabetes"},{"key":"BFnrgastro201349_CR65","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn, S. E., Hull, R. L. & Utzschneider, K. M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840\u2013846 (2006).","journal-title":"Nature"},{"key":"BFnrgastro201349_CR66","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000085276","volume":"5","author":"ST Chari","year":"2005","unstructured":"Chari, S. T., Zapiach, M., Yadav, D. & Rizza, R. A. \u03b2-cell function and insulin resistance evaluated by HOMA in pancreatic cancer subjects with varying degrees of glucose intolerance. Pancreatology 5, 229\u2013233 (2005).","journal-title":"Pancreatology"},{"key":"BFnrgastro201349_CR67","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1056\/NEJM199402033300503","volume":"330","author":"J Permert","year":"1994","unstructured":"Permert, J. et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N. Engl. J. Med. 330, 313\u2013318 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201349_CR68","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cca.2006.03.027","volume":"372","author":"D Basso","year":"2006","unstructured":"Basso, D. et al. Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause? Clin. Chim. Acta 372, 120\u2013128 (2006).","journal-title":"Clin. Chim. Acta"},{"key":"BFnrgastro201349_CR69","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cccn.2005.03.025","volume":"357","author":"D Basso","year":"2005","unstructured":"Basso, D. et al. Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications. Clin. Chim. Acta 357, 184\u2013189 (2005).","journal-title":"Clin. Chim. Acta"},{"key":"BFnrgastro201349_CR70","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1053\/j.gastro.2012.08.044","volume":"143","author":"G Aggarwal","year":"2012","unstructured":"Aggarwal, G. et al. Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in \u03b2 cells and mice. Gastroenterology 143, 1510\u20131517 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201349_CR71","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1210\/endo.137.6.8641217","volume":"137","author":"A Martinez","year":"1996","unstructured":"Martinez, A. et al. Regulation of insulin secretion and blood glucose metabolism by adrenomedullin. Endocrinology 137, 2626\u20132632 (1996).","journal-title":"Endocrinology"},{"key":"BFnrgastro201349_CR72","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.1152\/ajpendo.00213.2005","volume":"291","author":"N Sekine","year":"2006","unstructured":"Sekine, N., Takano, K., Kimata-Hayashi, N., Kadowaki, T. & Fujita, T. Adrenomedullin inhibits insulin exocytosis via pertussis toxin-sensitive G protein-coupled mechanism. Am. J. Physiol. Endocrinol. Metab. 291, E9\u2013E14 (2006).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrgastro201349_CR73","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0167-0115(03)00030-2","volume":"112","author":"E Zudaire","year":"2003","unstructured":"Zudaire, E., Cuttitta, F. & Martinez, A. Regulation of pancreatic physiology by adrenomedullin and its binding protein. Regu. Pept. 112, 121\u2013130 (2003).","journal-title":"Regu. Pept."},{"key":"BFnrgastro201349_CR74","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1476-5381.2011.01530.x","volume":"166","author":"Y Hong","year":"2012","unstructured":"Hong, Y., Hay, D. L., Quirion, R. & Poyner, D. R. The pharmacology of adrenomedullin 2\/intermedin. Br. J. Pharmacol. 166, 110\u2013120 (2012).","journal-title":"Br. J. Pharmacol."},{"key":"BFnrgastro201349_CR75","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/ijc.22596","volume":"121","author":"S Keleg","year":"2007","unstructured":"Keleg, S. et al. Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion. Int. J. Cancer 121, 21\u201332 (2007).","journal-title":"Int. J. Cancer"},{"key":"BFnrgastro201349_CR76","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1016\/j.yexcr.2007.06.013","volume":"313","author":"M Natsuizaka","year":"2007","unstructured":"Natsuizaka, M. et al. Synergistic up-regulation of Hexokinase-2, glucose transporters and angiogenic factors in pancreatic cancer cells by glucose deprivation and hypoxia. Exp. Cell Res. 313, 3337\u20133348 (2007).","journal-title":"Exp. Cell Res."},{"key":"BFnrgastro201349_CR77","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cmet.2012.07.004","volume":"16","author":"AC Konner","year":"2012","unstructured":"Konner, A. C. & Bruning, J. C. Selective insulin and leptin resistance in metabolic disorders. Cell. Metab. 16, 144\u2013152 (2012).","journal-title":"Cell. Metab."},{"key":"BFnrgastro201349_CR78","first-page":"1232","volume":"85","author":"J Liu","year":"2000","unstructured":"Liu, J. et al. The intracellular mechanism of insulin resistance in pancreatic cancer patients. J. Clin. Endocrinol. Metab. 85, 1232\u20131238 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrgastro201349_CR79","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00006676-200303000-00014","volume":"26","author":"B Isaksson","year":"2003","unstructured":"Isaksson, B. et al. Impaired insulin action on phosphatidylinositol 3-kinase activity and glucose transport in skeletal muscle of pancreatic cancer patients. Pancreas 26, 173\u2013177 (2003).","journal-title":"Pancreas"},{"key":"BFnrgastro201349_CR80","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00006676-200201000-00002","volume":"24","author":"D Basso","year":"2002","unstructured":"Basso, D. et al. Putative pancreatic cancer-associated diabetogenic factor: 2030 MW peptide. Pancreas 24, 8\u201314 (2002).","journal-title":"Pancreas"},{"key":"BFnrgastro201349_CR81","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0168-8227(92)90068-3","volume":"15","author":"H Tabata","year":"1992","unstructured":"Tabata, H. et al. Islet amyloid polypeptide (IAPP\/amylin) causes insulin resistance in perfused rat hindlimb muscle. Diabetes Res. Clin. Pract. 15, 57\u201361 (1992).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"BFnrgastro201349_CR82","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0016-5085(98)70641-9","volume":"114","author":"X Ding","year":"1998","unstructured":"Ding, X., Flatt, P. R., Permert, J. & Adrian, T. E. Pancreatic cancer cells selectively stimulate islet \u03b2 cells to secrete amylin. Gastroenterology 114, 130\u2013138 (1998).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201349_CR83","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00006676-199905000-00012","volume":"18","author":"F Wang","year":"1999","unstructured":"Wang, F., Adrian, T. E., Westermark, G., Gasslander, T. & Permert, J. Dissociated insulin and islet amyloid polypeptide secretion from isolated rat pancreatic islets cocultured with human pancreatic adenocarcinoma cells. Pancreas 18, 403\u2013409 (1999).","journal-title":"Pancreas"},{"key":"BFnrgastro201349_CR84","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF02822387","volume":"21","author":"F Wang","year":"1997","unstructured":"Wang, F. et al. Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines. Int. J. Pancreatol. 21, 157\u2013164 (1997).","journal-title":"Int. J. Pancreatol."},{"key":"BFnrgastro201349_CR85","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","volume":"148","author":"VT Samuel","year":"2012","unstructured":"Samuel, V. T. & Shulman, G. I. Mechanisms for insulin resistance: common threads and missing links. Cell 148, 852\u2013871 (2012).","journal-title":"Cell"},{"key":"BFnrgastro201349_CR86","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/MED.0b013e3283514e13","volume":"19","author":"OT Hardy","year":"2012","unstructured":"Hardy, O. T., Czech, M. P. & Corvera, S. What causes the insulin resistance underlying obesity? Curr. Opin. Endocrinol. Diabetes Obes. 19, 81\u201387 (2012).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"BFnrgastro201349_CR87","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","volume":"72","author":"JM Olefsky","year":"2010","unstructured":"Olefsky, J. M. & Glass, C. K. Macrophages, inflammation, and insulin resistance. Ann. Rev. Physiol. 72, 219\u2013246 (2010).","journal-title":"Ann. Rev. Physiol."},{"key":"BFnrgastro201349_CR88","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1549-8719.2011.00130.x","volume":"19","author":"MP De Boer","year":"2012","unstructured":"De Boer, M. P. et al. Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Microcirculation 19, 5\u201318 (2012).","journal-title":"Microcirculation"},{"key":"BFnrgastro201349_CR89","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.beem.2005.07.008","volume":"19","author":"A Koerner","year":"2005","unstructured":"Koerner, A., Kratzsch, J. & Kiess, W. Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come. Best Pract. Res. Clin. Endocrinol. Metab. 19, 525\u2013546 (2005).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"BFnrgastro201349_CR90","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.2174\/138161210791208893","volume":"16","author":"Y Matsuzawa","year":"2010","unstructured":"Matsuzawa, Y. Adiponectin: a key player in obesity related disorders. Curr. Pharm. Des. 16, 1896\u20131901 (2010).","journal-title":"Curr. Pharm. Des."},{"key":"BFnrgastro201349_CR91","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.metabol.2007.09.011","volume":"57","author":"N Oda","year":"2008","unstructured":"Oda, N. et al. The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism 57, 268\u2013273 (2008).","journal-title":"Metabolism"},{"key":"BFnrgastro201349_CR92","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","volume":"29","author":"MF Gregor","year":"2011","unstructured":"Gregor, M. F. & Hotamisligil, G. S. Inflammatory mechanisms in obesity. Ann. Rev. Immunol. 29, 415\u2013445 (2011).","journal-title":"Ann. Rev. Immunol."},{"key":"BFnrgastro201349_CR93","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.2279","volume":"17","author":"B Vandanmagsar","year":"2011","unstructured":"Vandanmagsar, B. et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179\u2013188 (2011).","journal-title":"Nat. Med."},{"key":"BFnrgastro201349_CR94","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cmet.2011.10.011","volume":"15","author":"R Stienstra","year":"2012","unstructured":"Stienstra, R., Tack, C. J., Kanneganti, T. D., Joosten, L. A. & Netea, M. G. The inflammasome puts obesity in the danger zone. Cell. Metab. 15, 10\u201318 (2012).","journal-title":"Cell. Metab."},{"key":"BFnrgastro201349_CR95","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1016\/j.febslet.2006.04.028","volume":"580","author":"Y Matsuzawa","year":"2006","unstructured":"Matsuzawa, Y. The metabolic syndrome and adipocytokines. FEBS Lett. 580, 2917\u20132921 (2006).","journal-title":"FEBS Lett."},{"key":"BFnrgastro201349_CR96","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1038\/bjc.2012.172","volume":"106","author":"VA Grote","year":"2012","unstructured":"Grote, V. A. et al. Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Br. J. Cancer 106, 1866\u20131874 (2012).","journal-title":"Br. J. Cancer"},{"key":"BFnrgastro201349_CR97","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrgastro.2011.4","volume":"8","author":"MM Smits","year":"2011","unstructured":"Smits, M. M. & van Geenen, E. J. The clinical significance of pancreatic steatosis. Nat. Rev. Gastroenterol. Hepatol. 8, 169\u2013177 (2011).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro201349_CR98","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2174\/157339912799424564","volume":"8","author":"D Gupta","year":"2012","unstructured":"Gupta, D., Krueger, C. B. & Lastra, G. Over-nutrition, obesity and insulin resistance in the development of \u03b2-cell dysfunction. Curr. Diabetes Rev. 8, 76\u201383 (2012).","journal-title":"Curr. Diabetes Rev."},{"key":"BFnrgastro201349_CR99","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/SPC.0b013e328331c897","volume":"3","author":"MJ Tisdale","year":"2009","unstructured":"Tisdale, M. J. Zinc- \u03b1-2-glycoprotein in cachexia and obesity. Curr. Opin. Support Palliat. Care 3, 288\u2013293 (2009).","journal-title":"Curr. Opin. Support Palliat. Care"},{"key":"BFnrgastro201349_CR100","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/ijo.2010.105","volume":"34","author":"C Bing","year":"2010","unstructured":"Bing, C., Mracek, T., Gao, D. & Trayhurn, P. Zinc- \u03b1-2-glycoprotein: an adipokine modulator of body fat mass? Int. J. Obes. (Lond.) 34, 1559\u20131565 (2010).","journal-title":"Int. J. Obes. (Lond.)"},{"issue":"Suppl. 7","key":"BFnrgastro201349_CR101","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1038\/ijo.2008.243","volume":"32","author":"Y Matsuzawa","year":"2008","unstructured":"Matsuzawa, Y. The role of fat topology in the risk of disease. Int. J. Obes. (Lond.) 32 (Suppl. 7), S83\u2013S92 (2008).","journal-title":"Int. J. Obes. (Lond.)"},{"key":"BFnrgastro201349_CR102","doi-asserted-by":"publisher","first-page":"629","DOI":"10.5551\/jat.7922","volume":"18","author":"Y Matsuzawa","year":"2011","unstructured":"Matsuzawa, Y., Funahashi, T. & Nakamura, T. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J. Atheroscler. Thromb. 18, 629\u2013639 (2011).","journal-title":"J. Atheroscler. Thromb."},{"key":"BFnrgastro201349_CR103","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2183\/pjab.86.131","volume":"86","author":"Y Matsuzawa","year":"2010","unstructured":"Matsuzawa, Y. Establishment of a concept of visceral fat syndrome and discovery of adiponectin. Proc. Jpn Acad. Ser. B Phys. Biol. Sci. 86, 131\u2013141 (2010).","journal-title":"Proc. Jpn Acad. Ser. B Phys. Biol. Sci."},{"key":"BFnrgastro201349_CR104","doi-asserted-by":"publisher","first-page":"E1756","DOI":"10.1210\/jc.2011-0615","volume":"96","author":"T McLaughlin","year":"2011","unstructured":"McLaughlin, T., Lamendola, C., Liu, A. & Abbasi, F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J. Clin. Endocrinol. Metab. 96, E1756\u2013E1760 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrgastro201349_CR105","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1056\/NEJMoa033179","volume":"350","author":"S Klein","year":"2004","unstructured":"Klein, S. et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N. Engl. J. Med. 350, 2549\u20132557 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201349_CR106","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.2337\/diabetes.51.10.2951","volume":"51","author":"I Gabriely","year":"2002","unstructured":"Gabriely, I. et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 51, 2951\u20138 (2002).","journal-title":"Diabetes"},{"key":"BFnrgastro201349_CR107","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/sj.ijo.0801871","volume":"26","author":"A Thorne","year":"2002","unstructured":"Thorne, A., Lonnqvist, F., Apelman, J., Hellers, G. & Arner, P. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int. J. Obes. (Lond.) 26, 193\u2013199 (2002).","journal-title":"Int. J. Obes. (Lond.)"},{"key":"BFnrgastro201349_CR108","first-page":"11","volume":"11","author":"MM Ibrahim","year":"2010","unstructured":"Ibrahim, M. M. Subcutaneous and visceral adipose tissue: structural and functional differences. Int. J. Obes. (Lond.) 11, 11\u201318 (2010).","journal-title":"Int. J. Obes. (Lond.)"},{"key":"BFnrgastro201349_CR109","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/oby.2009.443","volume":"18","author":"K Samaras","year":"2010","unstructured":"Samaras, K., Botelho, N. K., Chisholm, D. J. & Lord, R. V. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Obesity 18, 884\u2013889 (2010).","journal-title":"Obesity"},{"key":"BFnrgastro201349_CR110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.124.3215.269","volume":"124","author":"O Warburg","year":"1956","unstructured":"Warburg, O. On respiratory impairment in cancer cells. Science 124, 269\u2013270 (1956).","journal-title":"Science"},{"key":"BFnrgastro201349_CR111","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00423-012-0933-9","volume":"397","author":"I Regel","year":"2012","unstructured":"Regel, I. et al. Energy metabolism and proliferation in pancreatic carcinogenesis. Langenbecks Arch. Surg. 397, 507\u2013512 (2012).","journal-title":"Langenbecks Arch. Surg."},{"key":"BFnrgastro201349_CR112","doi-asserted-by":"publisher","first-page":"e32996","DOI":"10.1371\/journal.pone.0032996","volume":"7","author":"NV Chaika","year":"2012","unstructured":"Chaika, N. V. et al. Differential expression of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocarcinoma. PLoS ONE 7, e32996 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrgastro201349_CR113","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1158\/1940-6207.CAPR-10-0247","volume":"4","author":"X Dong","year":"2011","unstructured":"Dong, X. et al. Glucose metabolism gene variants modulate the risk of pancreatic cancer. Cancer Prev. Res. (Phila.) 4, 758\u2013766 (2011).","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"BFnrgastro201349_CR114","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","volume":"149","author":"H Ying","year":"2012","unstructured":"Ying, H. et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 149, 656\u2013670 (2012).","journal-title":"Cell"},{"key":"BFnrgastro201349_CR115","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nrgastro.2012.63","volume":"9","author":"PK Singh","year":"2012","unstructured":"Singh, P. K., Brand, R. E. & Mehla, K. MicroRNAs in pancreatic cancer metabolism. Nat. Rev. Gastroenterol. Hepatol. 9, 334\u2013344 (2012).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro201349_CR116","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.cmet.2011.03.014","volume":"13","author":"J Ferrer","year":"2011","unstructured":"Ferrer, J. Glucose as a mitogenic hormone. Cell Metab. 13, 357\u2013358 (2011).","journal-title":"Cell Metab."},{"key":"BFnrgastro201349_CR117","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1158\/1055-9965.EPI-11-0066","volume":"20","author":"L Jiao","year":"2011","unstructured":"Jiao, L. et al. Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 20, 1430\u20131438 (2011).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"BFnrgastro201349_CR118","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1158\/0008-5472.CAN-10-2573","volume":"71","author":"L Jiao","year":"2011","unstructured":"Jiao, L. et al. Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study. Cancer Res. 71, 3582\u20133589 (2011).","journal-title":"Cancer Res."},{"key":"BFnrgastro201349_CR119","doi-asserted-by":"publisher","first-page":"e27074","DOI":"10.1371\/journal.pone.0027074","volume":"6","author":"L Han","year":"2011","unstructured":"Han, L. et al. High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR. PLoS ONE 6, e27074 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrgastro201349_CR120","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-009-1556-8","volume":"53","author":"AE Butler","year":"2010","unstructured":"Butler, A. E. et al. Pancreatic duct replication is increased with obesity and type 2 diabetes in humans. Diabetologia 53, 21\u201326 (2010).","journal-title":"Diabetologia"},{"key":"BFnrgastro201349_CR121","doi-asserted-by":"publisher","first-page":"e17385","DOI":"10.1371\/journal.pone.0017385","volume":"6","author":"J Li","year":"2011","unstructured":"Li, J. et al. Relationship between neural alteration and perineural invasion in pancreatic cancer patients with hyperglycemia. PLoS ONE 6, e17385 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrgastro201349_CR122","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1001\/jama.294.22.2872","volume":"294","author":"RZ Stolzenberg-Solomon","year":"2005","unstructured":"Stolzenberg-Solomon, R. Z. et al. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 294, 2872\u20132878 (2005).","journal-title":"JAMA"},{"key":"BFnrgastro201349_CR123","doi-asserted-by":"publisher","first-page":"7031","DOI":"10.1073\/pnas.1113865109","volume":"109","author":"R Kang","year":"2012","unstructured":"Kang, R. et al. The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia. Proc. Natl Acad. Sci. USA 109, 7031\u20137036 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201349_CR124","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1158\/1078-0432.CCR-12-0221","volume":"18","author":"T Arumugam","year":"2012","unstructured":"Arumugam, T., Ramachandran, V., Gomez, S. B., Schmidt, A. M. & Logsdon, C. D. S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis. Clin. Cancer Res. 18, 4356\u20134364 (2012).","journal-title":"Clin. Cancer Res."},{"key":"BFnrgastro201349_CR125","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1158\/1055-9965.EPI-11-1139","volume":"21","author":"VA Grote","year":"2012","unstructured":"Grote, V. A. et al. The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC Cohort. Cancer Epidemiol. Biomarkers Prev. 21, 619\u2013628 (2012).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"BFnrgastro201349_CR126","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1158\/0008-5472.CAN-10-2573","volume":"71","author":"L Jiao","year":"2011","unstructured":"Jiao, L. et al. Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study. Cancer Res. 71, 3582\u20133589 (2011).","journal-title":"Cancer Res."},{"key":"BFnrgastro201349_CR127","doi-asserted-by":"publisher","first-page":"10264","DOI":"10.1158\/0008-5472.CAN-06-2321","volume":"66","author":"MH Muders","year":"2006","unstructured":"Muders, M. H. et al. Expression and regulatory role of GAIP-interacting protein GIPC in pancreatic adenocarcinoma. Cancer Res. 66, 10264\u201310268 (2006).","journal-title":"Cancer Res."},{"key":"BFnrgastro201349_CR128","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak, M. Insulin and insulin-like growth factor signalling in neoplasia. Nat. Rev. Cancer 8, 915\u2013928 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnrgastro201349_CR129","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1158\/1078-0432.CCR-09-2229","volume":"16","author":"E Rozengurt","year":"2010","unstructured":"Rozengurt, E., Sinnett-Smith, J. & Kisfalvi, K. Crosstalk between insulin\/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer. Clin. Cancer Res. 16, 2505\u20132511 (2010).","journal-title":"Clin. Cancer Res."},{"key":"BFnrgastro201349_CR130","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1136\/gut.2005.082990","volume":"55","author":"H Mehenni","year":"2006","unstructured":"Mehenni, H. et al. Cancer risks in LKB1 germline mutation carriers. Gut 55, 984\u2013990 (2006).","journal-title":"Gut"},{"key":"BFnrgastro201349_CR131","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/gcc.20870","volume":"50","author":"DJ Birnbaum","year":"2011","unstructured":"Birnbaum, D. J. et al. Genome profiling of pancreatic adenocarcinoma. Genes Chromosomes Cancer 50, 456\u2013465 (2011).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrgastro201349_CR132","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1093\/carcin\/bgs151","volume":"33","author":"D Li","year":"2012","unstructured":"Li, D. et al. Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis 33, 1384\u20131390 (2012).","journal-title":"Carcinogenesis"},{"key":"BFnrgastro201349_CR133","doi-asserted-by":"publisher","first-page":"13787","DOI":"10.1073\/pnas.1203339109","volume":"109","author":"NV Chaika","year":"2012","unstructured":"Chaika, N. V. et al. MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 \u03b1 to regulate metabolism in pancreatic cancer. Proc. Natl Acad. Sci. USA 109, 13787\u201313792 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro201349_CR134","first-page":"6548","volume":"61","author":"N Akakura","year":"2001","unstructured":"Akakura, N. et al. Constitutive expression of hypoxia-inducible factor-1 \u03b1 renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res. 61, 6548\u20136554 (2001).","journal-title":"Cancer Res."},{"key":"BFnrgastro201349_CR135","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/S0002-9440(10)63924-7","volume":"162","author":"J Chen","year":"2003","unstructured":"Chen, J. et al. Dominant-negative hypoxia-inducible factor-1 \u03b1 reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am. J. Pathol. 162, 1283\u201312891 (2003).","journal-title":"Am. J. Pathol."},{"key":"BFnrgastro201349_CR136","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1470-2045(08)70337-1","volume":"10","author":"R Pannala","year":"2009","unstructured":"Pannala, R., Basu, A., Petersen, G. M. & Chari, S. T. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol. 10, 88\u201395 (2009).","journal-title":"Lancet Oncol."},{"issue":"Suppl. 2","key":"BFnrgastro201349_CR137","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.2337\/dc08-s244","volume":"31","author":"PD Hardt","year":"2008","unstructured":"Hardt, P. D., Brendel, M. D., Kloer, H. U. & Bretzel, R. G. Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed? Diabetes Care 31 (Suppl. 2), S165\u2013S169 (2008).","journal-title":"Diabetes Care"},{"key":"BFnrgastro201349_CR138","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1097\/MCG.0b013e31822a2ae5","volume":"45","author":"N Chen","year":"2011","unstructured":"Chen, N., Unnikrishnan, I. R., Anjana, R. M., Mohan, V. & Pitchumoni, C. S. The complex exocrine-endocrine relationship and secondary diabetes in exocrine pancreatic disorders. J. Clin. Gastroenterol. 45, 850\u2013861 (2011).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnrgastro201349_CR139","doi-asserted-by":"crossref","unstructured":"Diagnosis and classification of diabetes mellitus. Diabetes Care 33 (Suppl. 1), S62\u2013S69 (2010).","DOI":"10.2337\/dc10-S062"},{"key":"BFnrgastro201349_CR140","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000329188","volume":"11","author":"Y Cui","year":"2011","unstructured":"Cui, Y. & Andersen, D. K. Pancreatogenic diabetes: special considerations for management. Pancreatology 11, 279\u2013294 (2011).","journal-title":"Pancreatology"},{"key":"BFnrgastro201349_CR141","unstructured":"Raue, G. & Keim, V. Secondary diabetes in chronic pancreatitis [German]. Z. Gastroenterol. (Suppl. 1), 4\u20139 (1999)."},{"key":"BFnrgastro201349_CR142","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/00000658-198601000-00013","volume":"203","author":"R Tsuchiya","year":"1986","unstructured":"Tsuchiya, R. et al. Collective review of small carcinomas of the pancreas. Ann. Surg. 203, 77\u201381 (1986).","journal-title":"Ann. Surg."},{"key":"BFnrgastro201349_CR143","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/1520-6866(2001)21:1<59::AID-TCM6>3.0.CO;2-V","volume":"21","author":"J Permert","year":"2001","unstructured":"Permert, J., Herrington, M., Kazakoff, K., Pour, P. M. & Adrian, T. E. Early changes in islet hormone secretion in the hamster pancreatic cancer model. Teratog. Carcinog. Mutagen. 21, 59\u201367 (2001).","journal-title":"Teratog. Carcinog. Mutagen."},{"key":"BFnrgastro201349_CR144","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF02576207","volume":"193","author":"B Ahren","year":"1993","unstructured":"Ahren, B. & Andren-Sandberg, A. Glucose tolerance and insulin secretion in experimental pancreatic cancer in the Syrian hamster. Res. Exp. Med. (Berl.) 193, 21\u201326 (1993).","journal-title":"Res. Exp. Med. (Berl.)"},{"key":"BFnrgastro201349_CR145","first-page":"6396","volume":"49","author":"PM Pour","year":"1989","unstructured":"Pour, P. M. & Bell, R. H. Alteration of pancreatic endocrine cell patterns and their secretion during pancreatic carcinogenesis in the hamster model. Cancer Res. 49, 6396\u20136400 (1989).","journal-title":"Cancer Res."},{"key":"BFnrgastro201349_CR146","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/00006676-199708000-00004","volume":"15","author":"D Basso","year":"1997","unstructured":"Basso, D. et al. An unidentified pancreatic cancer cell product alters some intracellular pathways of glucose metabolism in isolated rat hepatocytes. Pancreas 15, 132\u2013138 (1997).","journal-title":"Pancreas"},{"key":"BFnrgastro201349_CR147","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1006\/bbrc.1999.0521","volume":"257","author":"A Valerio","year":"1999","unstructured":"Valerio, A. et al. Glucose metabolic alterations in isolated and perfused rat hepatocytes induced by pancreatic cancer conditioned medium: a low molecular weight factor possibly involved. Biochem. Biophys. Res. Commun. 257, 622\u2013628 (1999).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrgastro201349_CR148","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1136\/gut.2003.024471","volume":"53","author":"D Basso","year":"2004","unstructured":"Basso, D. et al. Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes. Gut 53, 1159\u20131166 (2004).","journal-title":"Gut"},{"key":"BFnrgastro201349_CR149","first-page":"2585","volume":"15","author":"D Basso","year":"1995","unstructured":"Basso, D. et al. The pancreatic cancer cell line MIA PaCa2 produces one or more factors able to induce hyperglycemia in SCID mice. Anticancer Res. 15, 2585\u20132588 (1995).","journal-title":"Anticancer Res."},{"key":"BFnrgastro201349_CR150","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1006\/jsre.1998.5393","volume":"79","author":"F Wang","year":"1998","unstructured":"Wang, F., Larsson, J., Adrian, T. E., Gasslander, T. & Permert, J. In vitro influences between pancreatic adenocarcinoma cells and pancreatic islets. J. Surg. Res. 79, 13\u201319 (1998).","journal-title":"J. Surg. Res."}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2013.49.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2013.49","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2013.49.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:49:29Z","timestamp":1684468169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2013.49"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,26]]},"references-count":150,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["BFnrgastro201349"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2013.49","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,26]]}}}